20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Significant increase in the prevalence of Panton–Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, particularly the USA300 variant ΨUSA300, in the Japanese community

      research-article
      1 , 1 , 1 , 1 , 1 , 1 , 2 , 3 , 4 , 5 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 12 , 13 , 14 , 15 , 16 , 17 , 1 ,
      Microbiology Spectrum
      American Society for Microbiology
      methicillin-resistant Staphylococcus aureus , Panton–Valentine leukocidin, USA300, ΨUSA300

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          USA300, a major Panton–Valentine leukocidin (PVL)-producing methicillin-resistant Staphylococcus aureus (MRSA) clone associated with skin and soft tissue infections (SSTIs), carries a type IV staphylococcal cassette chromosome mec (SCC mec) element. Recently, a USA300 variant, ΨUSA300, with a 12-bp deletion of ccrB2 in the SCC mec element, was identified in Japan by Takadama et al. (15). To understand the current status of PVL-positive MRSA in the community, a nationwide surveillance of MRSA isolated from outpatients at dermatology departments was conducted. This study included 1,619 outpatients who visited dermatology departments at 22 healthcare facilities in 11 prefectures in Japan between 2018 and 2021; S. aureus were isolated from these outpatients. Molecular epidemiological analysis was performed using PCR, SCC mec and spa typing, pulsed-field gel electrophoresis, multilocus sequence typing, and antimicrobial susceptibility testing. A total of 980 S. aureus were isolated, 293 of which were identified as MRSA. Among MRSA isolates, PVL genes were detected in 18 of 63 (28.6%) in 2018, 34 of 85 (40.0%) in 2019, 29 of 65 (44.6%) in 2020, and 40 in 80 (50.0%) in 2021. Among the PVL-positive MRSA, 16 of 121 (13.2%) and 94 of 121 (77.7%) isolates were identified as USA300 and ΨUSA300, respectively. ΨUSA300 strains were collected from six prefectures in Japan: Kagawa, Osaka, Tokyo, Kanagawa, Fukushima, and Saitama. ΨUSA300 was isolated more frequently than USA300 from patients with deep-seated SSTIs ( P < 0.05). Our findings showed that PVL-positive MRSA isolates were significantly increased in the Japanese community. Furthermore, the USA300 variant ΨUSA300 has emerged as the predominant PVL-positive MRSA clone across the Kanto, Kinki, and Shikoku regions of Japan, and this variant may possess a greater propensity to cause deep-seated SSTIs than in USA300.

          IMPORTANCE

          USA300 is an MRSA clone producing PVL, a toxin associated with SSTIs. ΨUSA300 is a USA300 variant recently identified in Japan by Takadama et al. (15). Here, we found that the prevalence rate of PVL-positive MRSA in S. aureus was elevated in the Japanese community, and ΨUSA300 accounted for most of them. ΨUSA300 strains have been isolated from several areas in Japan and were associated with deep-seated SSTIs. This study highlighted the emerging threat posed by ΨUSA300 in Japan.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

          Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections. This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of each of these clinical entities. The past 2 decades have witnessed two clear shifts in the epidemiology of S. aureus infections: first, a growing number of health care-associated infections, particularly seen in infective endocarditis and prosthetic device infections, and second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to β-lactam antibiotics. In reviewing the literature to support management strategies for these clinical manifestations, we also highlight the paucity of high-quality evidence for many key clinical questions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

            Between 1986 and 1998, eight cases of community-acquired pneumonia due to Staphylococcus aureus strains carrying the gene for the Panton-Valentine leukocidin (PVL) were recorded in France, six of which were fatal. We aimed to assess the clinical features of these eight cases, and those of other cases identified prospectively, and to compare them with the characteristics of patients with pneumonia caused by PVL-negative strains. We compared eight retrospective and eight prospective cases of PVL-positive S aureus pneumonia with 36 cases of PVL-negative S aureus pneumonia. For all patients, we recorded age, length of hospital stay, risk factors for infection, signs and symptoms, laboratory findings, antibiotic treatment, and serial radiological findings. Median age was 14.8 years (IQR 5.4-24.0) for the PVL-positive patients and 70.1 years (59.2-81.4) for the others (p=0.001). Influenza-like illness had occurred during the 2 days before admission in 12 of the 16 PVL-positive patients, but in only three of 33 PVL-negative patients (p<0.001). PVL-positive infections were more often marked by: temperature greater than 39 degrees C (p=0.01), heart rate above 140 beats per min (p=0.02), haemoptysis (p=0.005), onset of pleural effusion during hospital stay (p=0.004), and leucopenia (p=0.001). The survival rate 48 h after admission was 63% for the PVL-positive patients and 94% for PVL-negative individuals (p=0.007). Histopathological examination of lungs at necropsy from three cases of necrotising pneumonia associated with PVL-positive S aureus showed extensive necrotic ulcerations of the tracheal and bronchial mucosa and massive haemorrhagic necrosis of interalveolar septa. PVL-producing S aureus strains cause rapidly progressive, haemorrhagic, necrotising pneumonia, mainly in otherwise healthy children and young adults. The pneumonia is often preceded by influenza-like symptoms and has a high lethality rate.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

              A panel of national experts was convened by the Infectious Diseases Society of America (IDSA) to update the 2005 guidelines for the treatment of skin and soft tissue infections (SSTIs). The panel's recommendations were developed to be concordant with the recently published IDSA guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections. The focus of this guideline is the diagnosis and appropriate treatment of diverse SSTIs ranging from minor superficial infections to life-threatening infections such as necrotizing fasciitis. In addition, because of an increasing number of immunocompromised hosts worldwide, the guideline addresses the wide array of SSTIs that occur in this population. These guidelines emphasize the importance of clinical skills in promptly diagnosing SSTIs, identifying the pathogen, and administering effective treatments in a timely fashion. © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Writing – original draft
                Role: Data curationRole: Investigation
                Role: Data curationRole: Investigation
                Role: Data curationRole: Investigation
                Role: Data curationRole: Investigation
                Role: Data curationRole: Investigation
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: Resources
                Role: ConceptualizationRole: Data curationRole: Funding acquisitionRole: Project administrationRole: SupervisionRole: ValidationRole: Writing – review and editing
                Role: Editor
                Journal
                Microbiol Spectr
                Microbiol Spectr
                spectrum
                Microbiology Spectrum
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                2165-0497
                Nov-Dec 2023
                06 November 2023
                06 November 2023
                : 11
                : 6
                : e01248-23
                Affiliations
                [1 ] Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences; , Tokyo, Japan
                [2 ] Department of Dermatology, Takamatsu Red Cross Hospital; , Kagawa, Japan
                [3 ] Sapporo Skin Clinic; , Hokkaido, Japan
                [4 ] Department of Dermatology, Kanagawa Children’s Medical Center; , Kanagawa, Japan
                [5 ] Department of Dermatology, Hirosaki University Graduate School of Medicine; , Aomori, Japan
                [6 ] Shimoe Dermatology Clinic; , Osaka, Japan
                [7 ] Atopia Clinic; , Kumamoto, Japan
                [8 ] Kobayashi Dermatology Clinic; , Tokyo, Japan
                [9 ] Kawasaki Dermatology Clinic; , Tokyo, Japan
                [10 ] Ueki Dermatology Plastic Surgery; , Tokyo, Japan
                [11 ] Kawano Dermatology Clinic; , Tokyo, Japan
                [12 ] Department of Dermatology, Seirei Mikatahara General Hospital; , Shizuoka, Japan
                [13 ] Hasegawa Dermatology Clinic; , Fukushima, Japan
                [14 ] Furukawa Dermatology Clinic; , Fukushima, Japan
                [15 ] Division of Dermatology, Saitama Citizens Medical Center; , Saitama, Japan
                [16 ] Isonokami Dermatological Clinic; , Osaka, Japan
                [17 ] Fujita Dermatological Clinic; , Niigata, Japan
                University of Calgary; , Calgary, Alberta, Canada
                Author notes
                Address correspondence to Hidemasa Nakaminami, nakami@ 123456toyaku.ac.jp

                The authors declare no conflict of interest.

                Author information
                https://orcid.org/0000-0002-3782-8122
                https://orcid.org/0000-0003-2889-8257
                Article
                01248-23 spectrum.01248-23
                10.1128/spectrum.01248-23
                10715091
                37929951
                99ceb016-562b-4cba-a4aa-583f6f1628a4
                Copyright © 2023 Kaneko et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 23 March 2023
                : 02 October 2023
                Page count
                supplementary-material: 5, authors: 25, Figures: 2, Tables: 2, References: 52, Pages: 14, Words: 8270
                Funding
                Funded by: Japan Society for the Promotion of Science (JSPS);
                Award ID: 18K06797
                Award Recipient :
                Funded by: MEXT | Japan Society for the Promotion of Science (JSPS);
                Award ID: 23K07928
                Award Recipient :
                Funded by: MEXT | Japan Society for the Promotion of Science (JSPS);
                Award ID: 23KJ1957
                Award Recipient :
                Categories
                Research Article
                epidemiology, Epidemiology
                Custom metadata
                November/December 2023

                methicillin-resistant staphylococcus aureus ,panton–valentine leukocidin,usa300,ψusa300

                Comments

                Comment on this article